1. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.
Li L, Yin Q, Kuss P, Maliga Z, Millán JL, Wu H, Mitchison TJ.
Nat Chem Biol. 2014 Dec;10(12):1043-8. doi: 10.1038/nchembio.1661. Epub 2014 Oct 26. Erratum in: Nat Chem Biol. 2015 Mar;11(3):235.
PMID: 25344812

PDF

2. Anticancer flavonoids are mouse-selective STING agonists.

Kim S, Li L, Maliga Z, Yin Q, Wu H, Mitchison TJ.
ACS Chem Biol. 2013 Jul 19;8(7):1396-401. doi: 10.1021/cb400264n. Epub 2013 May 23.
PMID: 23683494

PDF

3. Spatial control of cell fate using synthetic surfaces to potentiate TGF-beta signaling.
Li L, Klim JR, Derda R, Courtney AH, Kiessling LL.
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11745-50. doi: 10.1073/pnas.1101454108. Epub 2011 Jun 30.
PMID: 21719709 

PDF

4. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells.
Klim JR, Li L, Wrighton PJ, Piekarczyk MS, Kiessling LL.
Nat Methods. 2010 Dec;7(12):989-94. doi: 10.1038/nmeth.1532. Epub 2010 Nov 14.
PMID: 21076418

PDF

5. Peptide ligands that use a novel binding site to target both TGF-β receptors.
Li L, Orner BP, Huang T, Hinck AP, Kiessling LL.
Mol Biosyst. 2010 Dec;6(12):2392-402. doi: 10.1039/c0mb00115e. Epub 2010 Oct 4.
PMID: 20890540

PDF

6. High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells.
Derda R, Musah S, Orner BP, Klim JR, Li L, Kiessling LL.
J Am Chem Soc. 2010 Feb 3;132(4):1289-95. doi: 10.1021/ja906089g.
PMID: 20067240

PDF

7. Defined substrates for human embryonic stem cell growth identified from surface arrays.
Derda R, Li L, Orner BP, Lewis RL, Thomson JA, Kiessling LL.
ACS Chem Biol. 2007 May 22;2(5):347-55. Epub 2007 May 4.
PMID: 17480050

PDF